STOP FENTANYL PACKAGE
Latest action · Aug 4, 2022 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedAug 4, 2022
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Streamlining Text for Official Policy by Formulating Effective Needed Tools to Address Narcotics, Yearly Loss of life and Protect Americans from Chemical Killers and Against Gangs Effectively Act or the STOP FENTANYL PACKAGE
This bill temporarily expands access to drugs that reverse opioid overdoses and makes other changes to drug control activities.
The bill expands the authority of health care providers to distribute, and the authority of first responders and lay administrators to administer, opioid overdose reversal drugs. Health care providers may distribute the drugs to those at risk of an overdose or others in the community able to assist an individual at such risk. Additionally, the bill provides immunity from civil and criminal liability and other adverse actions for injuries that arise from distributing or administering those drugs unless the injury was caused by gross negligence or willful or wanton misconduct. The authority and liability protections terminate 90 days after the Department of Health and Human Services (HHS) terminates the on-going opioid public health emergency first declared on October 26, 2017, and the bill preempts state laws that provide lesser protections.
Further, the Department of Justice (DOJ) must support training for law enforcement on drug-related matters and upgrading laboratories; HHS and DOJ may award grants for improving data collection and surveillance concerning overdoses. The bill also expands existing drug control activities. For example, recipients may use their community policing grants to procure equipment that protects first responders from secondary fentanyl exposure.
Other matters addressed in the bill include
- interagency coordination of drug control activities;
- uniform reporting standards for information concerning drug control activities;
- budgeting for a program that analyzes fentanyl samples; and
- challenges with implementing State Opioid Response grants.
Cosponsors
Members who signed on, in the order they did.
Actions 2
Everything that happened, newest first.
- Aug 4, 2022Introduced in Senate
- Aug 4, 2022Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Aug 4, 2022Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.